| DIRECT COMPETITOR COMPARISON | |
| MBRX | Pvt1 | LLY | GSK | Industry | | Market Cap: | 15.47M | N/A | 40.53B | 105.15B | 105.30M | | Employees: | 52 | 53,1001 | 40,500 | 99,003 | 68 | | Qtrly Rev Growth (yoy): | 248.30% | N/A | 6.80% | 14.90% | 19.10% | | Revenue (ttm): | 18.26M | 20.81B1 | 21.11B | 43.51B | 13.84M | | Gross Margin (ttm): | 11.82% | N/A | 82.33% | 76.27% | 65.67% | | EBITDA (ttm): | -5.71M | N/A | 7.74B | 17.15B | -11.53M | | Oper Margins (ttm): | -40.96% | N/A | 30.97% | 34.30% | -149.46% | | Net Income (ttm): | -12.36M | N/A | -216.00M | 7.82B | N/A | | EPS (ttm): | -0.352 | N/A | -0.197 | 3.06 | -0.31 | | P/E (ttm): | N/A | N/A | N/A | 13.56 | 20.71 | | PEG (5 yr expected): | N/A | N/A | 6.68 | 3.02 | 1.35 | | P/S (ttm): | 0.85 | N/A | 1.92 | 2.42 | 10.16 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.27 | 0.00% | 56.95B | 12.27 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.99 | 0.00% | 15.32B | 17.73 | | Genzyme Corp. | GENZ | 51.13 | 0.00% | 13.57B | 29.15 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 44.87 | 0.00% | 40.38B | 17.35 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.25 | 0.00% | 9.14B | 1045.92 | | Teva Pharmaceutical Industries Limited | TEVA | 56.84 | 0.00% | 50.08B | 52.00 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.70 | 0.00% | 4.21B | 20.46 | | King Pharmaceuticals Inc. | KG | 12.73 | 0.00% | 3.16B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.03 | 0.00% | 5.51B | 110.61 | | Pfizer Inc. | PFE | 18.53 | 0.00% | 149.53B | 15.39 | | Johnson & Johnson | JNJ | 63.99 | 0.00% | 176.55B | 13.97 | | GlaxoSmithKline plc | GSK | 41.48 | 0.00% | 105.15B | 13.56 | | Sanofi-Aventis | SNY | 40.06 | 0.00% | 104.60B | N/A | | Novartis AG | NVS | 51.91 | 0.00% | 117.90B | 15.54 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.09 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.58 | 0.00% | 67.54B | 9.35 | | Abbott Laboratories | ABT | 54.77 | 0.00% | 84.71B | 14.84 | | Bristol-Myers Squibb Co. | BMY | 25.24 | 0.00% | 50.00B | 13.06 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|